COVID-19 JN.1 variant: Oncology experts share the possible impacts on cancer patients, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

India’s first JN.1 case was reported from Kerela, and a total of 511 cases of JN.1 have since been reported from 11 states until January 2, 2024. ETHealthworld spoke to oncologists across the nation to understand the impact of JN.1 on patients undergoing cancer treatment. Since cancer patients are immunocompromised, they are at a high risk of contracting the virus and suffering from severe infections or succumbing to COVID-related complications., India’s first JN.1 case was reported from Kerela, and a total of 511 cases of JN.1 have since been reported from 11 states until January 2, 2024. ETHealthworld spoke to oncologists across the nation to understand the impact of JN.1 on patients undergoing cancer treatment. Since cancer patients are immunocompromised, they are at a high risk of contracting the virus and suffering from severe infections or succumbing to COVID-related complications., , Read More